Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company
Abzena
Abzena
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
The IoT edge: Elevating cleanroom monitoring to new heights in the era of Pharma 4.0
In the rapidly evolving landscape of pharmaceutical manufacturing, the integration of cutting-edge technologies is not just a trend but a necessity to meet the stringent...
ChargePoint launches robotic solution for GMP manufacturing
ChargePoint Technology has launched a new robotic material handling solution aimed at increasing safety and efficiency in solid-dosage drug manufacturing
Fraser Anti-Static Techniques launches US cleanroom product brand to the UK and Ireland markets
Static Clean International's static cleaning product range has now been made available to UK and Ireland-based companies through a new partnership
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
AVM Group: The history behind the cleanroom industry merger
US-based cleanroom and containment expert AVM Group talked exclusively to Cleanroom Technology about the history behind the separate companies and the project collaborations...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Design & Build
Abzena selects IPS for design and build of turnkey cGMP facility
Biopharma expert Abzena has chosen IPS to perform full design, construction management, and CQV services for its new monoclonal antibody (mAb) facility
Design & Build
Abzena takes modular approach to biologics suites
This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas
Finance
Abzena invests $60m into cGMP manufacturing capacity
The investment was reportedly driven by both existing customer requirements and by wider market demand
Richard Milbank joins Abzena
Design & Build
Abzena invests in new GMP biologics drug manufacturing plant
CEO announces US$20m investment into the expansion of biologics drug substance and ADC capabilities at new San Diego site
Pharmaceutical
Abzena and Telix sign manufacturing and bioconjugation agreement
The agreement between the developer and manufacturer of biopharmaceuticals and the radio-pharmaceuticals specialist is worth US$5.9 million
Pharmaceutical
Abzena chooses Sartorius
Sartorius Stedim Biotech has been named the preferred equipment supplier to Abzena CDMO facilities in the US
Subscribe now